Chemoinformaics analysis of Isobutyl isovalerate
| Molecular Weight | 158.241 | nRot | 4 |
| Heavy Atom Molecular Weight | 140.097 | nRig | 7 |
| Exact Molecular Weight | 158.131 | nRing | 0 |
| Solubility: LogS | -0.417 | nHRing | 0 |
| Solubility: LogP | -2.283 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 28.6363 |
| nHD | 0 | BPOL | 20.6617 |
| QED | 0.56 |
| Synth | 2.524 |
| Natural Product Likeliness | -0.447 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.006 |
| HIA | 0.624 |
| CACO-2 | -6.015 |
| MDCK | 0.00240524 |
| BBB | 0.524 |
| PPB | 0.0924827 |
| VDSS | 0.559 |
| FU | 0.876051 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.076 |
| CYP2c19-inh | 0.03 |
| CYP2c19-sub | 0.054 |
| CYP2c9-inh | 0.035 |
| CYP2c9-sub | 0.681 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.156 |
| CYP3a4-inh | 0.008 |
| CYP3a4-sub | 0.017 |
| CL | 3.534 |
| T12 | 0.755 |
| hERG | 0.014 |
| Ames | 0.008 |
| ROA | 0.01 |
| SkinSen | 0.287 |
| Carcinogencity | 0.019 |
| EI | 0.072 |
| Respiratory | 0.053 |
| NR-Aromatase | 0.011 |
| Antiviral | No |
| Prediction | 0.93698 |